Travel Medicine Advisor Archives – May 1, 2011
May 1, 2011
View Issues
-
Histoplasmosis in Travelers
Twice in the past 2 years I've encountered pulmonary histoplasmosis in travelers returning from Central America (Mexico and Costa Rica), and both times the diagnosis proved challenging. One case, in particular, was a 60-year-old man who had traveled to Costa Rica for 1 week and then presented with fever, persistent dry cough, malaise, and complaints of memory loss. -
Real-life Efficacy of Herpes Zoster Vaccine
Herpes zoster vaccine (Zostavax) was licensed in the United States in 2006 subsequent to the publication of the Shingles Prevention Study, a large (n = 38,546) prospective trial that demonstrated a 51% reduction in zoster and a 67% reduction in postherpetic neuralgia in vaccines compared to controls. -
Leptospirosis in Florida: Recreational Exposures Reveal New Serovar
Leptospirosis is a zoonosis caused by multiple serovars of bacteria in the genus Leptospira that are widely distributed in the tropics, as well as some subtropical and temperate areas. -
MDR-TB in South African Health Care Workers
Admissions to a public hospital in kwazulu-natal, South Africa, for treatment of MDR- and XDR-TB from 2003 to 2008 were examined for health care workers (HCWs) compared with non-HCWs. -
Pharmacology Watch: Tiotropium for COPD — The New Standard?
In this issue: Anticholinergic drugs for COPD; pioglitazone for diabetes prevention; insulin degludec in Phase 3 trials; and FDA Actions.